Poster presentation

A multi-axis biomarker model integrating KIM-1 and MAdCAM-1 in metastatic renal cell carcinoma

ASCO Annual Meeting 2025 June 01, 2026 Chicago, IL, USA

Evaluating whether integrating KIM-1 and MAdCAM-1 into a composite risk score improves risk stratification beyond either biomarker alone and beyond IMDC criteria in metastatic renal carcinoma.

Back to presentations